Rising Pharmaceuticals Inc., a finished dosage form generics subsidiary of ACETO Corporation, has launched the generic version of the 75mg/5mL strength of Clindamycin Palmitate Hydrochloride for oral solution, USP (pediatric), an FDA approved generic version of Pfizer Inc.'s Cleocin Pediatric.
According to IMS Health data, US market sales for Clindamycin Palmitate Hydrochloride, which is an antibiotic that is used to treat serious infections caused by bacteria, were approximately $59 million for the twelve months ended June 30, 2012.
ACETO Corporation is a global leader in the marketing, sale and distribution of products for human health (finished dosage form generics and nutraceutical products), pharmaceutical ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and performance chemicals (specialty chemicals and agricultural protection products).